Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Movicol vs Lactulose for Faecal Impaction and Maintenance in Children
NCT00404040Phase 2Completed
- Sponsor
- Norgine
- Start
- Oct 2000
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of polyethylene glycol in fecal impaction and chronic constipation (2 arms), sponsored by Norgine. Primary endpoints: Efficacy of Maintenance Therapy at 12 weeks and Safety of Maintenance Therapy at 12 weeks. Started Oct 2000; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
fecal impactionchronic constipation
Beyond the preview
Go deeper on NCT00404040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404040.